Pharmacologic Therapies Effective for Excessive Daytime Sleepiness
Solriamfetol, armodafinil-modafinil, and pitolisant reduce daytime sleepiness, with solriamfetol likely superior.
Stay updated with breaking news from Wakefulness Test. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Solriamfetol, armodafinil-modafinil, and pitolisant reduce daytime sleepiness, with solriamfetol likely superior.
Solriamfetol had particularly strong showing in network meta-analysis
The FDA has granted final approval to Lumryz (sodium oxybate) for the treatment of cataplexy or excessive daytime sleepiness in adults with narcolepsy.
The FDA has granted final approval to Lumryz (sodium oxybate) for the treatment of cataplexy or excessive daytime sleepiness in adults with narcolepsy.
A SLEEP 2022 poster presents a post-hoc analysis of pooled data from patients in WAKIX pivotal clinical trials who had a high burden of narcolepsy.